Aptitude Health: Company Profile

Background

Overview

Aptitude Health is a global leader in providing evidence-based solutions for life science companies focused on oncology and hematology. Established in 2004, the company specializes in transforming scientific and clinical knowledge into actionable insights that enhance patient outcomes. With a robust network of over 2,200 global disease-state experts and healthcare professionals, Aptitude Health has become the strategic partner of choice for leading life science companies.

Mission and Vision

Aptitude Health's mission is to empower life science companies to identify, develop, and commercialize oncology and hematology innovations by providing comprehensive market insights and strategic solutions. The company's vision is to be the premier partner for transforming scientific knowledge into improved patient care and outcomes.

Primary Area of Focus

The company's primary focus is on oncology and hematology, offering services that span the entire product lifecycle—from discovery and clinical development to commercialization. Aptitude Health's expertise encompasses solid tumors, hematologic malignancies, benign hematologic disorders, and supportive care.

Industry Significance

Aptitude Health holds a significant position in the healthcare consulting industry, particularly within oncology and hematology. The company's evidence-based solutions and extensive network of experts have been instrumental in supporting the development and commercialization of numerous oncology drugs, contributing to advancements in cancer treatment and patient care.

Key Strategic Focus

Core Objectives

Aptitude Health aims to deliver actionable insights and strategic recommendations that enable life science companies to navigate the complexities of oncology and hematology markets effectively. The company's objectives include:

• Providing comprehensive business intelligence to inform clinical and commercial decisions.

• Facilitating medical communications to disseminate critical clinical information.

• Developing medical publications that contribute to enhanced clinician knowledge.

• Leveraging real-world evidence to drive evidence-based decisions and strategies.

Specific Areas of Specialization

Aptitude Health specializes in:

• Oncology and hematology market research.

• Medical communications and publications.

• Real-world evidence generation and analysis.

• Strategic consultancy for life science companies.

Key Technologies Utilized

The company employs advanced technologies, including:

• Artificial intelligence (AI) for patient case simulations and data analysis.

• Proprietary platforms for business intelligence and market research.

• Real-world data integration to enhance insights and decision-making.

Primary Markets Targeted

Aptitude Health primarily targets:

• Pharmaceutical and biotechnology companies specializing in oncology and hematology.

• Healthcare providers and clinicians involved in cancer care.

• Regulatory bodies and organizations focused on oncology and hematology.

Financials and Funding

Funding History

In April 2021, Aptitude Health received a majority investment from Linden Capital Partners, a Chicago-based healthcare private equity firm. This partnership aimed to accelerate the company's growth and expand its service offerings.

Total Funds Raised

The exact total funds raised by Aptitude Health are not publicly disclosed.

Notable Investors

Linden Capital Partners is a notable investor in Aptitude Health.

Intended Utilization of Capital

The capital from Linden Capital Partners was intended to:

• Support the expansion of Aptitude Health's service capabilities.

• Enhance the company's technological platforms.

• Broaden the solution suite to sustain market leadership.

Pipeline Development

Key Pipeline Candidates

Aptitude Health's pipeline includes:

• OncoClinicAI: An AI-driven patient case-simulation platform designed to gather treatment-related insights for oncology life science companies.

Stages of Development

OncoClinicAI was launched in February 2025, indicating its early stages of deployment.

Target Conditions

The platform focuses on oncology, aiming to provide insights into treatment pathways and decision-making processes.

Anticipated Milestones

As a recent launch, OncoClinicAI is expected to undergo continuous updates and enhancements to improve its capabilities and user experience.

Technological Platform and Innovation

Proprietary Technologies

Aptitude Health's proprietary technologies include:

• OncoClinicAI: An AI-driven platform for simulating real-world patient journeys in oncology.

Significant Scientific Methods

The company employs:

• AI-driven patient case simulations to analyze treatment decisions.

• Real-world data integration to enhance market insights.

AI-Driven Capabilities

OncoClinicAI exemplifies Aptitude Health's commitment to integrating AI into healthcare, providing scalable, data-driven insights that inform oncology brand strategies.

Leadership Team

Executive Profiles

• Jez Moulding: Chief Executive Officer. Jez has over 20 years of experience in general management and regional president roles within the healthcare industry, having worked in various countries for Sanofi.

• Jason Cash: Chief Financial Officer. Jason oversees the financial operations of Aptitude Health, ensuring fiscal responsibility and strategic financial planning.

• Stefanie Daniels: Chief Commercial Officer. Stefanie brings over 20 years of experience in oncology, having previously served as a senior director at Physicians' Education Resource.

• Adam Sinensky: Chief Technology Officer. Adam has over 20 years of experience in the healthcare industry, focusing on product and strategy leadership in technology.

• Kelley Hernandez: Executive Vice President, US Business Development. Kelley has over 18 years of experience in the oncology space, contributing to business development strategies.

• Adrian Barfield: Vice President, US Business Development. Adrian has 32 years of commercial experience in oncology, focusing on revenue generation and team building.

• Eugene Vissers, MD: Senior Vice President, Global Scientific Content. Eugene brings a clinical background combined with business acumen to develop innovative strategies in medical content.

• Sandra Mendes, PhD, CMPP: Vice President, Medical Publications. Sandra oversees the development and dissemination of scientific data to improve clinician knowledge.

• Bart Zygmond: Vice President, Finance. Bart manages the financial aspects of Aptitude Health, ensuring financial health and strategic growth.

• Kelly Kocor: Vice President, People & Culture. Kelly focuses on fostering a positive organizational culture and managing human resources.

• Erin Zingales Rau: Vice President, Account Services. Erin leads the account services team, ensuring client satisfaction and service excellence.

Competitor Profile

Market Insights and Dynamics

The oncology and hematology consulting market is characterized by rapid advancements in cancer research, increasing demand for personalized medicine, and a growing emphasis on real-world evidence. Companies in this space must navigate complex regulatory environments and adapt to evolving healthcare landscapes.

Competitor Analysis

Key competitors to Aptitude Health include:

• Trinity Life Sciences: Specializes in life sciences commercialization and analytics services, offering planning, market access, pricing, launch, and brand optimization.

• PRMA Consulting: Provides strategic market access and pricing consultancy services, focusing on the pharmaceutical and biotechnology sectors.

• Precision Value & Health: Offers integrated commercialization solutions, including market access, pricing, and patient services, to support pharmaceutical and biotech companies.